PulseAugur
EN
LIVE 17:26:21
한국어(KO) Derya Unutmaz, MD (@DeryaTR_) 약물 개발이 10년에서 수개월·수주·수일로 단축될 수 있으며, 대부분의 실험이 사람 대상 검증 전에 시뮬레이션에서 먼저 수행되는 방향으로 바뀔 수 있다는 전망이다. 개인 맞춤형 의약품의 가능성도 제기했다. https:// x.com/

AI Poised to Revolutionize Drug Development Timelines

By PulseAugur Editorial · [1 sources] ·

Dr. Derya Unutmaz predicts that artificial intelligence could drastically shorten drug development timelines, potentially reducing the process from a decade to mere months, weeks, or even days. This acceleration would be driven by a shift towards performing most experiments via simulation before human trials. Furthermore, AI may enable the development of personalized medicines tailored to individual patients. AI

IMPACT AI could significantly accelerate drug discovery and enable personalized medicine, transforming healthcare timelines and patient outcomes.

RANK_REASON The item discusses a research-oriented prediction about AI's impact on drug discovery, fitting the 'research' bucket. [lever_c_demoted from research: ic=1 ai=1.0]

Read on Mastodon — fosstodon.org →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

COVERAGE [1]

  1. Mastodon — fosstodon.org TIER_1 한국어(KO) · [email protected] ·

    Derya Unutmaz, MD (@DeryaTR_) predicts that drug development can be shortened from 10 years to months, weeks, or days, and that most experiments can be simulated before human trials. She also raised the possibility of personalized medicine. https:// x.com/

    Derya Unutmaz, MD (@DeryaTR_) 약물 개발이 10년에서 수개월·수주·수일로 단축될 수 있으며, 대부분의 실험이 사람 대상 검증 전에 시뮬레이션에서 먼저 수행되는 방향으로 바뀔 수 있다는 전망이다. 개인 맞춤형 의약품의 가능성도 제기했다. https:// x.com/DeryaTR_/status/20665701 14800160829 # drugdiscovery # simulation # personalizedmedicine # ai # research

RELATED TOPICS